Skip to content

Clinton E. Canal

Mercer University Health Sciences Center

2 papers in the library · 116 citations · publishing 2010-2023

Papers

The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen

Psychopharmacology February 19, 2010 Clinton E. Canal, U. B. Olaghere da Silva, P. Gresch et al. 111 citations

The hallucinogenic compound DOI triggers a head-twitch response in mice, which is considered a behavioral proxy for hallucinogenic effects in humans. This response depends on the 5-HT2A serotonin receptor, but the study shows it is also strongly modulated by the 5-HT2C receptor. Mice lacking the 5-HT2C receptor showed about 50% fewer head twitches after DOI administration. Blocking the 5-HT2C receptor with specific antagonists reduced the head-twitch response by at least half in two different mouse strains. Differences in the 5-HT2A receptor did not explain strain variations in the response, suggesting 5-HT2C receptor signaling or other modulators are involved. The finding calls for a reassessment of how hallucinogens work through serotonin receptors.

The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors

ACS Pharmacology & Translational Science September 18, 2023 Richa Tyagi, Tanishka S. Saraf, Clinton E. Canal 5 citations

A psychedelic tryptamine, DPT, completely prevented sound-induced seizures in a mouse model of fragile X syndrome at a 10 mg/kg dose but not at lower doses. Although DPT activates several serotonin receptors in the lab, blocking those receptors did not stop its anti-seizure effect, nor did blocking sigma1 receptors. The anti-seizure action appears independent of DPT's psychedelic properties. However, high doses of DPT caused convulsions on their own, indicating complex, dose-dependent effects.